Nobody Wants to See This Kind of Climax



On Friday, nearly a third of stocks in the S&P 500 managed to hit a 52-week high on that day alone. Then it skyrocketed to a stunning 78-year high on Monday.

Monday was odd in many respects, not the least being another surge in stocks setting 52-week highs. More than 44% of S&P members notched a high in the morning, the most since 1943.

The burst of gains and push to new highs early on Monday was reversed during the session, causing a spike in the number of stocks suffering a buying climax. This is triggered when a stock hits a 52-week high then reverses to close below the prior day's close, potentially a sign of exhaustion among buyers.

Our Backtest Engine shows that this is the 6th-largest number of climaxes in a single day since the inception of SPY.

S&P 500 buying climaxes reversals

Every time more than 95 stocks suffered a buying climax, the S&P 500 showed a loss over the next 1-2 months. There were few losses over the next 6-12 months, and they were relatively small.

Stat Box

The Nasdaq 100 trust, QQQ, enjoyed a large reversal after a gap down open larger than 1.5%. All 11 precedents in the fund's history took place during bear market environments. Reversals look pretty on a chart, but historically have been unsuccessful predictors.


What else we're looking at

  • Full returns after a surge in buying climaxes
  • What happens after a historic rise in the number of stocks at 52-week highs
  • Even with the surge, there was a curious divergence in other stocks
  • An easy way to use Leading Economic Indicators to consistently outperform

The post titled Nobody Wants to See This Kind of Climax was originally published as on SentimenTrader.com on 2021-05-12.

At SentimenTrader.com, our service is not focused on market timing per se, but rather risk management. That may be a distinction without a difference, but it's how we approach the markets. We study signs that suggest it is time to raise or lower market exposure as a function of risk relative to probable reward. It is all about risk-adjusted expectations given existing evidence. Learn more about our service , research, models and indicators.


Follow us on Twitter for up to the minute analysis of market action.


Not ready to signup up for a free trial yet?

Signup for our Daily Lite email to receive highlights of our daily report, research and studies.


Follow us on Twitter:

Subscribe to our Youtube Channel:


RSS Feed

Subscribe to the Blog RSS feed

Tags